Search results
Jump to navigation
Jump to search
- ...Interferon beta-1a#Avonex|Avonex]], [[:en:4-Aminopyridine|Fampyra]], [[:en:Interferon beta-1a#Plegridy|Plegridy]], [[:en:Dimethyl fumarate|Tecfidera]], [[:en:Nat ...チューリッヒ大学]]の[[Wikipedia:Charles Weissmann|Charles Weissmann]]（最初の製品である[[:en:interferon alpha|インターフェロンα]]を提供した）などの著名な生物学者によって[[:en:Geneva|ジュネーブ]]で設立された。GilbertとSha ...18 KB (923 words) - 13:51, 30 September 2023
- ...]]）の分泌の活性化や[[CpG dinucleotide/ja|CpGジヌクレオチド]]の放出による[[leukocytes/ja|白血球]]の[[interferon/ja|インターフェロン]] [[IFN-α/ja|IFN-α]]/[[IFNγ/ja|IFNγ]]産生活性、[[cytokines/ja|サイトカイン ...29 KB (1,051 words) - 23:05, 17 April 2024
- コレカルシフェロールは、[[vitamin D2/ja|ビタミンD<sub>2</sub>]]とは異なり、細菌やウイルスから身体を守る[[interferon type I/ja|インターフェロンI型]]シグナル伝達システムを刺激するようである。 ...21 KB (1,011 words) - 10:09, 12 April 2024
- ...ld Unit|感冒ユニット（CCU）]]が設立され、1956年にライノウイルスが発見された。1970年代、CCUはライノウイルス感染症の潜伏期に[[interferon/ja|インターフェロン]]を投与することで、ライノウイルス感染症からある程度保護されることを実証したが、実用的な治療法は開発されなかった。ライノウイル ...26 KB (988 words) - 22:34, 18 April 2024
- Cholecalciferol appears to stimulate the body's [[interferon type I]] signaling system that protects against bacteria and viruses, unlik ...18 KB (2,635 words) - 21:30, 11 April 2024
- Cholecalciferol appears to stimulate the body's [[interferon type I]] signaling system that protects against bacteria and viruses, unlik ...18 KB (2,713 words) - 21:28, 11 April 2024
- ...scovered in 1956. In the 1970s, the CCU demonstrated that treatment with [[interferon]] during the incubation phase of rhinovirus infection protects somewhat aga ...23 KB (3,328 words) - 21:40, 18 April 2024
- ...scovered in 1956. In the 1970s, the CCU demonstrated that treatment with [[interferon]] during the incubation phase of rhinovirus infection protects somewhat aga ...23 KB (3,414 words) - 21:40, 18 April 2024
- ...e/ja|ワクチン]]、[[immunoglobulin/ja|免疫グロブリン]]、[[immunosuppressant/ja|免疫抑制剤]]、[[interferon/ja|インターフェロン]]、[[monoclonal antibody/ja|モノクローナル抗体]] ...58 KB (1,845 words) - 17:09, 5 November 2023
- ...obulin G|IgG]] and [[IgA]] and release of [[CpG dinucleotide]]s inducing [[interferon]] [[IFN-α]]/[[IFNγ]] producing activity of [[leukocytes]] and [[cytokines]] ...25 KB (3,667 words) - 21:52, 17 April 2024
- *[[Interferon]]s (Interferons-α, -β, -γ) ...29 KB (3,642 words) - 16:31, 3 January 2023
- ...obulin G|IgG]] and [[IgA]] and release of [[CpG dinucleotide]]s inducing [[interferon]] [[IFN-α]]/[[IFNγ]] producing activity of [[leukocytes]] and [[cytokines]] ...26 KB (3,755 words) - 21:51, 17 April 2024
- ...|immunoglobulin]]s, [[immunosuppressant|immunosuppressant]]s, [[interferon|interferon]]s, [[monoclonal antibody|monoclonal antibodies]]. ...52 KB (6,923 words) - 17:09, 5 November 2023
- ...|immunoglobulin]]s, [[immunosuppressant|immunosuppressant]]s, [[interferon|interferon]]s, [[monoclonal antibody|monoclonal antibodies]]. ...54 KB (7,245 words) - 17:08, 5 November 2023
- .../id/eprint/1236240/1/Baxter_et_al-2007-The_Cochrane_library.pdf }}</ref> [[interferon]] to treat some cancers, [[erythropoietin]] for anemic patients, and [[tiss ...217 KB (29,051 words) - 07:55, 4 January 2023